arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Bausch & Lomb Corp

BLCO
$16.75 ▲ +0.41 (+2.51%) at close
Industrials ·Ophthalmic Goods ·USOphthalmic Goods
7 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
34
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bausch & Lomb Corp faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.9B
Dividend Yield
Revenue Growth 6.5%
Op. Margin 2.2%
ROIC 1.1%
FCF / Share $-0.19
Trailing P/E
Price / Book 0.9x
FCF Yield
Debt / Equity 0.78
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.10B
↑ +6.5%
Net Income Profit after all expenses
$-360.00M
↓ -13.6%
Operating Margin Operating profit as % of sales
2.2%
↓ -34.5% 34th
FCF / Share Free cash flow per share
$-0.19
↓ -11.2%
Long-Term Debt Long-term obligations
$5.05B
↑ +5.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
25
Returns
38
Financial Health
43
Cash Quality
29

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 24 quarters